Subsequent genome-wide association studies (GWAS) recently validated the SLC16A11 risk haplotype7–12 and most research focused on providing evidence for a causal relationship between the development of diabetes and changes in SLC16A11 function. The gene discussed is SLC16A11; the disease is diabetes mellitus.